Cellectis Provides Business Update and Reports Financial
ASH 2022 sponsored programs – UCART123 abstract selected for oral presentation & preclinical data on UCARTCS1 selected for poster presentation, in...
Source: globenewswire.com
Cellectis Sponsored Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cellectis Sponsored Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cellectis Sponsored Phase Today - Breaking & Trending Today
Cellectis Provides Business Update and Reports Financial Results for Second Quarter 2022
04.08.2022 - IND clearance received from FDA for UCART20x22 for the treatment of Non-Hodgkin LymphomaCellectis unveiled novel immune-evasive universal allogeneic CAR T-cell in Nature Communications; awarded oral presentation at ASGCT in MayMr. Axel-Sven ...
Source: wallstreet-online.de
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021 Enrollment ongoing in three Cellectis-sponsored Phase 1 dose-escalation clinical studies BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and MELANI-01 in r/r MM patients in 15 US clinical centers Five partnered allogeneic CAR-T product candidates in clinical development through our collaborations with Allogene and Servier: UCART19/ALLO-501 and ALLO-501A in r/r NHL, ALLO-715 and ALLO-605 in r/r MM and ALLO-316 in advanced or metastatic clear cell renal cell carcinoma New collaboration with Cyto...
Source: forextv.com